Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.
Boulder is a telehealth provider of treatment and long-term support for people with substance use disorders
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.
CODE 27 develops software solutions focused on digital platforms, data systems, and custom technology applications.
Video Rebirth is a private limited company that is established with shares.
Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.
The revolutionary platform for decentralized AI collaborations - unlock data silos without data sharing.
Powering precision proteomics to enable to the earliest detection of disease.
Green Energy Origin is a sustainable firm that develops specialty chemicals and battery raw materials for cost effective energy solutions.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Fasikl is a neuro-AI company that creates interfaces for the nervous system.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Biotechnology, Medical, Health Care, Therapeutics, Pharmaceutical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post-IPO Equity round. Qiming Venture Partners's total known invested capital is $20.5B.
Qiming Venture Partners's average investment size is $53.4M across its portfolio of 399 companies.
Recent Qiming Venture Partners portfolio additions include Cornerstone Robotics, AusperBio, Boulder Care, Leyden Labs, Entact Bio. These companies were founded in 2020 or later.